Alvine Pharmaceuticals, Inc. is a privately held biopharmaceutical company dedicated to developing and commercializing therapeutics for autoimmune/gastrointestinal diseases. Alvine's lead product candidate, ALV003, is a combination protease engineered to digest gluten. It is being developed to treat patients with celiac disease.
Current Team (12)Update
Chief Medical Officer, Senior Vice President, Development
Chief Business Officer, Senior Vice President
Vice President of Marketing and Corporate & Strategic Development
President and CEO
Vice President of Quality and Regulatory Affairs
Vice-President of Process and Product Development
Funding Rounds (6) - $138MUpdate
Board Members and Advisors (3)Update
Realizing entrepreneurial innovation is the mission of Flagship Ventures. The firm operates...
Global Investment Firm
Since 1974, Sofinnova Ventures has partnered with entrepreneurs to secure initial funding, build...
Prospect Venture Partners is a Palo Alto, California based venture capital firm with over $1B of...
InterWest invests an average of about $7 - 15 million over the span of their involvement with...
Panorama Capital invests in passionate entrepreneurs building leading companies in life sciences...
75 Shoreway Rd.
San Carlos, CA 94070